SCHEMBL30040899

SCHEMBL30040899

FC(F)c1ccccc1Nc1ccc2[nH]c(CSc3ccnc(C(F)(F)F)c3)nc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 2/20 0.37
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TAS2R14 Q9NYV8 1/20 0.36
▸ ABCB1 P08183 6/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PARP14 Q460N5 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618319 0.88 ABCB1 (0.42) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL26260644 0.88 NPC1 (0.40) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL26261593 0.88 NPC1 (0.38) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL23618304 0.88 NPC1 (0.40) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL25436191 0.86 SMN1; SMN2 (0.42) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL23618336 0.86 NPC1 (0.44) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL26260667 0.86 ENPP1 (0.39) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL26260655 0.85 PARP14 (0.43) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL30041437 0.85 ABCB1 (0.35) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL25400510 0.85 ABCB1 (0.35) PDE10ANPC1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085054-B1 NEW PQSR INVERSE AGONISTS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-02-19 — — EP disclosed
EP-4085054-A1 NEW PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
Send feedback